Orthodontic Consumables Market by Product Type (Adhesives, Aligners, Bands), Material Type (Ceramic, Metal, Polymer), Pricing Tier, End User, Distribution Channel - Global Forecast 2025-2032
Description
The Orthodontic Consumables Market was valued at USD 7.48 billion in 2024 and is projected to grow to USD 8.30 billion in 2025, with a CAGR of 11.04%, reaching USD 17.31 billion by 2032.
An authoritative orientation to the dynamic orthodontic consumables environment highlighting technological, clinical, and procurement shifts shaping stakeholder priorities
The orthodontic consumables sector is experiencing an accelerated phase of professionalization driven by technological refinement, evolving clinical protocols, and shifting procurement behaviors among providers. Practitioners and supply chain stakeholders are navigating a more diversified product set that now blends legacy mechanical solutions with digitally enabled offerings, and this convergence is reshaping purchasing criteria, clinical workflows, and supplier relationships.
This introduction provides a pragmatic orientation for senior executives and clinical procurement teams. It highlights the forces that matter most today: material science advances that alter handling and patient comfort, the introduction of aligner ecosystems that reframe treatment planning, and distribution innovations that influence lead times and cost structures. The narrative that follows will unpack these dynamics, focusing on structural shifts, tariff-driven trade pressures, segmentation-level intricacies, regional differentials, competitive positioning, and actionable steps for leaders aiming to strengthen resilience and capture value in a fast-changing environment.
The sector is reshaping rapidly as material innovation, aligner ecosystems, and distribution fragmentation converge to redefine clinical workflows and supplier value propositions
The landscape for orthodontic consumables is undergoing transformative shifts driven by the intersection of clinical innovation, supply chain reconfiguration, and buyer sophistication. Innovations in polymer chemistry and metallurgy are enabling thinner, more resilient wires and brackets, while adhesive evolution-both light cure and chemical cure-continues to improve chairside efficiency and bond reliability. At the same time, the growth of clear aligner solutions has expanded the consumables universe beyond traditional brackets-and-wires paradigms and is prompting manufacturers to rethink product portfolios and engagement models.
Concurrently, distribution channels are fragmenting as manufacturers balance direct sales with distributor partnerships and rapidly growing e-commerce options that serve both B2B and B2C customers. This fragmentation is changing how clinical practices source products and manage inventory, with digital platforms introducing greater transparency and competitive pricing. The combined effect of product innovation and distribution evolution is altering value propositions across the supply chain: suppliers must now demonstrate clinical efficacy, operational convenience, and predictable availability to secure long-term relationships with dental laboratories, hospitals, and orthodontic clinics.
Trade policy and tariff adjustments through 2025 have become a decisive operational risk reshaping sourcing, nearshoring choices, and supplier diversification strategies across the value chain
The imposition and adjustment of tariffs in the U.S. through 2025 have added a new vector of strategic complexity for suppliers and buyers of orthodontic consumables. Tariff changes have increased landed costs for certain imported components and finished goods, prompting manufacturers to reassess sourcing geographies, renegotiate supplier contracts, and prioritize components that can be localized or substituted without compromising clinical performance. Those upstream responses have downstream effects on inventory strategies and purchasing cadence for dental laboratories, hospitals, and clinics.
Moreover, tariff-driven cost pressures have accelerated conversations about nearshoring and supplier diversification. For some manufacturers, investing in regional production capacity or establishing contingency inventory hubs reduces exposure to tariff volatility and international logistics disruption. For purchasers, the immediate implications include a renewed focus on total procurement cost, lead-time variability, and contract clauses that accommodate changes in trade policy. In sum, tariffs through 2025 have catalyzed structural adjustments across the supply chain and elevated trade policy as a core operational risk that merits ongoing executive attention.
A multi-axis segmentation framework that dissects product types, material choices, end-user demands, distribution pathways, and pricing tiers to reveal precise sources of value and complexity
A granular segmentation lens reveals where value and risk concentrate across product, material, end-user, distribution, and pricing tiers. Based on Product Type, the landscape includes Adhesives, Aligners, Bands, Brackets, and Wires, with Adhesives further differentiated across Chemical Cure and Light Cure, Bands divided into Molar and Premolar, Brackets categorized as Conventional and Self Ligating, and Wires segmented into Beta Titanium, Nickel Titanium, and Stainless Steel; these distinctions drive procurement protocols and clinician preferences and determine inventory complexity for suppliers and purchasers.
Based on Material Type, product selection reflects choices among Ceramic, Metal, and Polymer, with Ceramic further classified into Monocrystalline and Polycrystalline, Metal into Cobalt Chrome, Nickel Titanium, and Stainless Steel, and Polymer into Thermoplastic and Thermoset; material selection influences aesthetics, strength, and processing requirements and directly affects manufacturing cost profiles and handling instructions. Based on End User, demand is channel-specific across Dental Laboratories, Hospitals, and Orthodontic Clinics, each with distinct purchasing cycles, regulatory exposure, and clinical throughput implications. Based on Distribution Channel, the industry is supplied through Direct Sales, Distributor Sales, and E Commerce, with E Commerce further splitting into B2B and B2C models that require different fulfillment and service approaches. Finally, Based on Pricing Tier, offerings span Economy, Mid Range, and Premium segments, with pricing tier determining margins, brand positioning, and the necessary investment in clinical evidence and marketing. Together, these segmentation dimensions form a multi-axis framework that explains product innovation adoption, differential supplier performance, and where service and differentiation create defensible propositions.
Regional competitive dynamics and regulatory variances across the Americas, Europe, Middle East & Africa, and Asia-Pacific that influence product adoption, sourcing, and commercial strategies
Regional dynamics continue to dictate competitive priorities and operational models across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, market behavior is characterized by a strong emphasis on clinical evidence, reimbursement interplay, and established prosthetic and orthodontic supply chains that favor integrated vendor relationships and predictable inventory management. Transition toward digital workflows in North America also elevates demand for aligner-compatible consumables and digitally integrated accessories.
In Europe, Middle East & Africa, regulatory harmonization, cost containment pressures, and a heterogeneous payer landscape create differentiated adoption rates for premium and novel materials. Manufacturers operating across EMEA must navigate varying certification requirements and regional distribution norms. The Asia-Pacific region is notable for rapid capacity expansion, considerable manufacturing depth, and rising clinical adoption of aesthetic and polymer-based solutions; growth in this region is also accompanied by increased competition and a strong emphasis on cost optimization. Across regions, differences in distribution infrastructure, clinical training paradigms, and procurement sophistication lead to varied strategic priorities for suppliers seeking to scale internationally.
Competitive positioning and strategic behaviors among incumbents and challengers revealing how R&D, distribution excellence, and clinical engagement determine sustained advantage
The competitive landscape is populated by established manufacturers, emerging specialized providers, and vertically integrated dental groups that are increasingly asserting control over consumables procurement. Leading firms that combine robust R&D capabilities with efficient production networks and well-structured distribution channels have a sustained advantage, particularly when their portfolios address both traditional orthodontic systems and aligner-compatible products. New entrants and niche specialists, meanwhile, create pressure on pricing and force incumbents to accelerate product refinement and customer service improvements.
Strategic alliances and targeted acquisitions remain common as organizations seek to fill capability gaps, broaden material portfolios, or gain entry into specific regional markets. Firms that invest in clinical evidence generation and practitioner training secure stronger clinical advocacy, which translates into more stable demand among orthodontic clinics and dental laboratories. Conversely, companies that rely solely on price competition without commensurate investments in quality assurance, logistics, and practitioner support risk margin erosion and channel displacement over time.
Practical and prioritized actions for manufacturers and distributors to combine product innovation, resilient sourcing, and tailored commercial models that secure long-term adoption
Leaders seeking to strengthen their position should pursue a balanced playbook that harmonizes product innovation, supply chain resilience, and commercial execution. Prioritize investments in material science and product ergonomics that directly reduce chair time or improve patient comfort, while simultaneously validating performance through peer-reviewed clinical studies and targeted practitioner training programs. This dual focus on performance evidence and clinician enablement will support premium positioning and foster adoption in conservative clinical settings.
Operationally, diversify sourcing to mitigate tariff exposure and consider incremental nearshoring or regional manufacturing partnerships to shorten lead times and increase responsiveness. Optimize distribution by combining direct account management for high-volume institutional clients with partner-led and e-commerce strategies for smaller clinics and laboratories. On commercial execution, tailor value propositions to end-user segments and pricing tiers: emphasize reliability and clinical support to hospitals and dental laboratories, while highlighting convenience, cost-per-case, and accessibility to orthodontic clinics. Finally, develop outcome-focused messaging and post-sale support offerings that convert initial adoption into long-term clinical preference and recurring procurement.
A robust mixed-methods research protocol combining primary stakeholder interviews, secondary technical synthesis, and supply chain analysis to ensure evidence-based findings
The research approach underpinning these insights integrates primary qualitative interviews, secondary technical literature review, and supply chain analysis to produce an evidence-driven narrative. Primary engagement included structured discussions with clinicians, procurement leaders, and distribution executives to surface day-to-day operational challenges, decision criteria, and adoption barriers. These conversations were synthesized to contextualize product-level dynamics and distribution trade-offs.
Secondary inputs drew on published clinical studies, materials science literature, regulatory guidance, and logistics data to corroborate practitioner perspectives and to validate assertions about material behavior, production constraints, and regional regulatory impacts. To assess trade policy effects, customs and tariff schedules were analyzed alongside manufacturer disclosures about sourcing adjustments and capacity investments. Cross-validation between primary and secondary sources was used to reduce bias and ensure that conclusions reflect both frontline experience and technical realities.
A conclusive synthesis underscoring the imperative to align clinical evidence, supply resilience, and tailored commercialization to secure enduring competitive advantage
In closing, the orthodontic consumables domain sits at the intersection of technical refinement and commercial transformation. Material innovations, the ascendancy of aligner-compatible ecosystems, distribution channel diversification, and trade policy shifts each exert meaningful influence on how products are developed, procured, and supported. Stakeholders that align product portfolios with clinician needs, shore up supply chains against trade volatility, and tailor go-to-market strategies by end-user and pricing segment will be best positioned to capture durable value.
The path forward requires disciplined investment in clinical validation, operational flexibility, and differentiated service models. Organizations that commit to these priorities will not only navigate near-term disruptions more effectively but will also create the foundations for sustainable commercial relationships and improved patient outcomes.
Please Note: PDF & Excel + Online Access - 1 Year
An authoritative orientation to the dynamic orthodontic consumables environment highlighting technological, clinical, and procurement shifts shaping stakeholder priorities
The orthodontic consumables sector is experiencing an accelerated phase of professionalization driven by technological refinement, evolving clinical protocols, and shifting procurement behaviors among providers. Practitioners and supply chain stakeholders are navigating a more diversified product set that now blends legacy mechanical solutions with digitally enabled offerings, and this convergence is reshaping purchasing criteria, clinical workflows, and supplier relationships.
This introduction provides a pragmatic orientation for senior executives and clinical procurement teams. It highlights the forces that matter most today: material science advances that alter handling and patient comfort, the introduction of aligner ecosystems that reframe treatment planning, and distribution innovations that influence lead times and cost structures. The narrative that follows will unpack these dynamics, focusing on structural shifts, tariff-driven trade pressures, segmentation-level intricacies, regional differentials, competitive positioning, and actionable steps for leaders aiming to strengthen resilience and capture value in a fast-changing environment.
The sector is reshaping rapidly as material innovation, aligner ecosystems, and distribution fragmentation converge to redefine clinical workflows and supplier value propositions
The landscape for orthodontic consumables is undergoing transformative shifts driven by the intersection of clinical innovation, supply chain reconfiguration, and buyer sophistication. Innovations in polymer chemistry and metallurgy are enabling thinner, more resilient wires and brackets, while adhesive evolution-both light cure and chemical cure-continues to improve chairside efficiency and bond reliability. At the same time, the growth of clear aligner solutions has expanded the consumables universe beyond traditional brackets-and-wires paradigms and is prompting manufacturers to rethink product portfolios and engagement models.
Concurrently, distribution channels are fragmenting as manufacturers balance direct sales with distributor partnerships and rapidly growing e-commerce options that serve both B2B and B2C customers. This fragmentation is changing how clinical practices source products and manage inventory, with digital platforms introducing greater transparency and competitive pricing. The combined effect of product innovation and distribution evolution is altering value propositions across the supply chain: suppliers must now demonstrate clinical efficacy, operational convenience, and predictable availability to secure long-term relationships with dental laboratories, hospitals, and orthodontic clinics.
Trade policy and tariff adjustments through 2025 have become a decisive operational risk reshaping sourcing, nearshoring choices, and supplier diversification strategies across the value chain
The imposition and adjustment of tariffs in the U.S. through 2025 have added a new vector of strategic complexity for suppliers and buyers of orthodontic consumables. Tariff changes have increased landed costs for certain imported components and finished goods, prompting manufacturers to reassess sourcing geographies, renegotiate supplier contracts, and prioritize components that can be localized or substituted without compromising clinical performance. Those upstream responses have downstream effects on inventory strategies and purchasing cadence for dental laboratories, hospitals, and clinics.
Moreover, tariff-driven cost pressures have accelerated conversations about nearshoring and supplier diversification. For some manufacturers, investing in regional production capacity or establishing contingency inventory hubs reduces exposure to tariff volatility and international logistics disruption. For purchasers, the immediate implications include a renewed focus on total procurement cost, lead-time variability, and contract clauses that accommodate changes in trade policy. In sum, tariffs through 2025 have catalyzed structural adjustments across the supply chain and elevated trade policy as a core operational risk that merits ongoing executive attention.
A multi-axis segmentation framework that dissects product types, material choices, end-user demands, distribution pathways, and pricing tiers to reveal precise sources of value and complexity
A granular segmentation lens reveals where value and risk concentrate across product, material, end-user, distribution, and pricing tiers. Based on Product Type, the landscape includes Adhesives, Aligners, Bands, Brackets, and Wires, with Adhesives further differentiated across Chemical Cure and Light Cure, Bands divided into Molar and Premolar, Brackets categorized as Conventional and Self Ligating, and Wires segmented into Beta Titanium, Nickel Titanium, and Stainless Steel; these distinctions drive procurement protocols and clinician preferences and determine inventory complexity for suppliers and purchasers.
Based on Material Type, product selection reflects choices among Ceramic, Metal, and Polymer, with Ceramic further classified into Monocrystalline and Polycrystalline, Metal into Cobalt Chrome, Nickel Titanium, and Stainless Steel, and Polymer into Thermoplastic and Thermoset; material selection influences aesthetics, strength, and processing requirements and directly affects manufacturing cost profiles and handling instructions. Based on End User, demand is channel-specific across Dental Laboratories, Hospitals, and Orthodontic Clinics, each with distinct purchasing cycles, regulatory exposure, and clinical throughput implications. Based on Distribution Channel, the industry is supplied through Direct Sales, Distributor Sales, and E Commerce, with E Commerce further splitting into B2B and B2C models that require different fulfillment and service approaches. Finally, Based on Pricing Tier, offerings span Economy, Mid Range, and Premium segments, with pricing tier determining margins, brand positioning, and the necessary investment in clinical evidence and marketing. Together, these segmentation dimensions form a multi-axis framework that explains product innovation adoption, differential supplier performance, and where service and differentiation create defensible propositions.
Regional competitive dynamics and regulatory variances across the Americas, Europe, Middle East & Africa, and Asia-Pacific that influence product adoption, sourcing, and commercial strategies
Regional dynamics continue to dictate competitive priorities and operational models across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, market behavior is characterized by a strong emphasis on clinical evidence, reimbursement interplay, and established prosthetic and orthodontic supply chains that favor integrated vendor relationships and predictable inventory management. Transition toward digital workflows in North America also elevates demand for aligner-compatible consumables and digitally integrated accessories.
In Europe, Middle East & Africa, regulatory harmonization, cost containment pressures, and a heterogeneous payer landscape create differentiated adoption rates for premium and novel materials. Manufacturers operating across EMEA must navigate varying certification requirements and regional distribution norms. The Asia-Pacific region is notable for rapid capacity expansion, considerable manufacturing depth, and rising clinical adoption of aesthetic and polymer-based solutions; growth in this region is also accompanied by increased competition and a strong emphasis on cost optimization. Across regions, differences in distribution infrastructure, clinical training paradigms, and procurement sophistication lead to varied strategic priorities for suppliers seeking to scale internationally.
Competitive positioning and strategic behaviors among incumbents and challengers revealing how R&D, distribution excellence, and clinical engagement determine sustained advantage
The competitive landscape is populated by established manufacturers, emerging specialized providers, and vertically integrated dental groups that are increasingly asserting control over consumables procurement. Leading firms that combine robust R&D capabilities with efficient production networks and well-structured distribution channels have a sustained advantage, particularly when their portfolios address both traditional orthodontic systems and aligner-compatible products. New entrants and niche specialists, meanwhile, create pressure on pricing and force incumbents to accelerate product refinement and customer service improvements.
Strategic alliances and targeted acquisitions remain common as organizations seek to fill capability gaps, broaden material portfolios, or gain entry into specific regional markets. Firms that invest in clinical evidence generation and practitioner training secure stronger clinical advocacy, which translates into more stable demand among orthodontic clinics and dental laboratories. Conversely, companies that rely solely on price competition without commensurate investments in quality assurance, logistics, and practitioner support risk margin erosion and channel displacement over time.
Practical and prioritized actions for manufacturers and distributors to combine product innovation, resilient sourcing, and tailored commercial models that secure long-term adoption
Leaders seeking to strengthen their position should pursue a balanced playbook that harmonizes product innovation, supply chain resilience, and commercial execution. Prioritize investments in material science and product ergonomics that directly reduce chair time or improve patient comfort, while simultaneously validating performance through peer-reviewed clinical studies and targeted practitioner training programs. This dual focus on performance evidence and clinician enablement will support premium positioning and foster adoption in conservative clinical settings.
Operationally, diversify sourcing to mitigate tariff exposure and consider incremental nearshoring or regional manufacturing partnerships to shorten lead times and increase responsiveness. Optimize distribution by combining direct account management for high-volume institutional clients with partner-led and e-commerce strategies for smaller clinics and laboratories. On commercial execution, tailor value propositions to end-user segments and pricing tiers: emphasize reliability and clinical support to hospitals and dental laboratories, while highlighting convenience, cost-per-case, and accessibility to orthodontic clinics. Finally, develop outcome-focused messaging and post-sale support offerings that convert initial adoption into long-term clinical preference and recurring procurement.
A robust mixed-methods research protocol combining primary stakeholder interviews, secondary technical synthesis, and supply chain analysis to ensure evidence-based findings
The research approach underpinning these insights integrates primary qualitative interviews, secondary technical literature review, and supply chain analysis to produce an evidence-driven narrative. Primary engagement included structured discussions with clinicians, procurement leaders, and distribution executives to surface day-to-day operational challenges, decision criteria, and adoption barriers. These conversations were synthesized to contextualize product-level dynamics and distribution trade-offs.
Secondary inputs drew on published clinical studies, materials science literature, regulatory guidance, and logistics data to corroborate practitioner perspectives and to validate assertions about material behavior, production constraints, and regional regulatory impacts. To assess trade policy effects, customs and tariff schedules were analyzed alongside manufacturer disclosures about sourcing adjustments and capacity investments. Cross-validation between primary and secondary sources was used to reduce bias and ensure that conclusions reflect both frontline experience and technical realities.
A conclusive synthesis underscoring the imperative to align clinical evidence, supply resilience, and tailored commercialization to secure enduring competitive advantage
In closing, the orthodontic consumables domain sits at the intersection of technical refinement and commercial transformation. Material innovations, the ascendancy of aligner-compatible ecosystems, distribution channel diversification, and trade policy shifts each exert meaningful influence on how products are developed, procured, and supported. Stakeholders that align product portfolios with clinician needs, shore up supply chains against trade volatility, and tailor go-to-market strategies by end-user and pricing segment will be best positioned to capture durable value.
The path forward requires disciplined investment in clinical validation, operational flexibility, and differentiated service models. Organizations that commit to these priorities will not only navigate near-term disruptions more effectively but will also create the foundations for sustainable commercial relationships and improved patient outcomes.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
184 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Increasing adoption of 3D printed customized orthodontic brackets and wires improving treatment precision
- 5.2. Growing demand for eco-friendly and biodegradable orthodontic ligatures to reduce plastic waste
- 5.3. Integration of smart sensors in orthodontic archwires for real-time force monitoring and treatment optimization
- 5.4. Shift towards digital workflow consumables including intraoral scanners and CAD/CAM fabricated aligners
- 5.5. Rising preference for ceramic and aesthetic bracket consumables among adult orthodontic patients
- 5.6. Emergence of antimicrobial and remineralizing coating technologies on elastomeric modules and archwires
- 5.7. Increasing collaboration with teleorthodontics platforms for remote monitoring consumable management
- 5.8. Development of low-friction self-ligating brackets and high-performance archwires for faster arch alignment
- 5.9. Expansion of subscription-based models for orthodontic supplies tailored to clinic inventory management
- 5.10. Utilization of AI-driven software for personalized consumable recommendations and predictive treatment outcomes
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Orthodontic Consumables Market, by Product Type
- 8.1. Adhesives
- 8.1.1. Chemical Cure
- 8.1.2. Light Cure
- 8.2. Aligners
- 8.3. Bands
- 8.3.1. Molar
- 8.3.2. Premolar
- 8.4. Brackets
- 8.4.1. Conventional
- 8.4.2. Self Ligating
- 8.5. Wires
- 8.5.1. Beta Titanium
- 8.5.2. Nickel Titanium
- 8.5.3. Stainless Steel
- 9. Orthodontic Consumables Market, by Material Type
- 9.1. Ceramic
- 9.1.1. Monocrystalline
- 9.1.2. Polycrystalline
- 9.2. Metal
- 9.2.1. Cobalt Chrome
- 9.2.2. Nickel Titanium
- 9.2.3. Stainless Steel
- 9.3. Polymer
- 9.3.1. Thermoplastic
- 9.3.2. Thermoset
- 10. Orthodontic Consumables Market, by Pricing Tier
- 10.1. Economy
- 10.2. Mid Range
- 10.3. Premium
- 11. Orthodontic Consumables Market, by End User
- 11.1. Dental Laboratories
- 11.2. Hospitals
- 11.3. Orthodontic Clinics
- 12. Orthodontic Consumables Market, by Distribution Channel
- 12.1. Direct Sales
- 12.2. Distributor Sales
- 12.3. E Commerce
- 12.3.1. B2B
- 12.3.2. B2C
- 13. Orthodontic Consumables Market, by Region
- 13.1. Americas
- 13.1.1. North America
- 13.1.2. Latin America
- 13.2. Europe, Middle East & Africa
- 13.2.1. Europe
- 13.2.2. Middle East
- 13.2.3. Africa
- 13.3. Asia-Pacific
- 14. Orthodontic Consumables Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
- 15. Orthodontic Consumables Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
- 16. Competitive Landscape
- 16.1. Market Share Analysis, 2024
- 16.2. FPNV Positioning Matrix, 2024
- 16.3. Competitive Analysis
- 16.3.1. 3M Company
- 16.3.2. 7 Seas Orthodontics S.A.
- 16.3.3. Aditek Orthodontics
- 16.3.4. Align Technology, Inc.
- 16.3.5. American Orthodontics Corporation
- 16.3.6. Astar Orthodontics Inc.
- 16.3.7. DB Orthodontics Limited
- 16.3.8. DENTAURUM GmbH & Co. KG
- 16.3.9. Dentsply Sirona Inc.
- 16.3.10. DynaFlex
- 16.3.11. Envista Holdings Corporation
- 16.3.12. Eurodonto Importação e Exportação Ltda
- 16.3.13. FORESTADENT Bernhard Förster GmbH
- 16.3.14. G&H Orthodontics Inc.
- 16.3.15. GC Corporation
- 16.3.16. GC International AG
- 16.3.17. Great Lakes Dental Technologies
- 16.3.18. Henry Schein, Inc.
- 16.3.19. Institut Straumann AG
- 16.3.20. JAW Products, Inc.
- 16.3.21. JISCOP Co., Ltd.
- 16.3.22. JJ Orthodontics Pvt.Ltd.
- 16.3.23. Kuraray Noritake Dental Inc.
- 16.3.24. Leone S.p.A.
- 16.3.25. Shofu Inc.
- 16.3.26. Straumann Group AG
- 16.3.27. Sun Medical Co., Ltd.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
